ANL 29.15 Increased By ▲ 0.63 (2.21%)
ASC 16.50 Decreased By ▼ -0.18 (-1.08%)
ASL 25.15 Increased By ▲ 1.39 (5.85%)
AVN 99.18 Increased By ▲ 4.94 (5.24%)
BOP 9.51 Increased By ▲ 0.04 (0.42%)
BYCO 9.36 Decreased By ▼ -0.20 (-2.09%)
DGKC 112.10 Increased By ▲ 1.60 (1.45%)
EPCL 47.55 Increased By ▲ 0.10 (0.21%)
FCCL 21.50 Increased By ▲ 0.22 (1.03%)
FFBL 28.84 Increased By ▲ 0.87 (3.11%)
FFL 19.23 Decreased By ▼ -0.04 (-0.21%)
HASCOL 14.08 Decreased By ▼ -0.23 (-1.61%)
HUBC 86.75 Increased By ▲ 0.75 (0.87%)
HUMNL 7.25 Decreased By ▼ -0.05 (-0.68%)
JSCL 32.39 Increased By ▲ 0.92 (2.92%)
KAPCO 40.81 Increased By ▲ 0.08 (0.2%)
KEL 4.18 Increased By ▲ 0.07 (1.7%)
LOTCHEM 15.99 Decreased By ▼ -0.21 (-1.3%)
MLCF 43.90 Increased By ▲ 0.89 (2.07%)
PAEL 40.06 Increased By ▲ 0.20 (0.5%)
PIBTL 13.04 Increased By ▲ 0.13 (1.01%)
POWER 11.65 Increased By ▲ 0.25 (2.19%)
PPL 93.72 Increased By ▲ 0.42 (0.45%)
PRL 23.80 No Change ▼ 0.00 (0%)
PTC 9.37 Increased By ▲ 0.07 (0.75%)
SILK 1.22 Increased By ▲ 0.02 (1.67%)
SNGP 44.60 Increased By ▲ 0.27 (0.61%)
TRG 114.93 Increased By ▲ 6.45 (5.95%)
UNITY 33.68 Increased By ▲ 0.53 (1.6%)
WTL 1.09 Decreased By ▼ -0.03 (-2.68%)
BR100 4,883 Increased By ▲ 27.56 (0.57%)
BR30 25,120 Increased By ▲ 395.68 (1.6%)
KSE100 46,088 Increased By ▲ 219.6 (0.48%)
KSE30 19,166 Increased By ▲ 104.54 (0.55%)

Coronavirus

US CDC reports 251,715 deaths from coronavirus
World

US CDC reports 251,715 deaths from coronavirus

  • The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus.
  • The CDC figures do not necessarily reflect cases reported by individual states.
Published 21 Nov, 2020 12:32am
Europe's COVID-19 cases surpass 15 million mark
World

Europe's COVID-19 cases surpass 15 million mark

  • While it took the region nearly nine months to record its first 5 million cases, the next 10 million cases were reported in less than two months, according to a Reuters analysis.
Published 20 Nov, 2020 06:59pm
Pfizer applies for U.S. emergency use for COVID-19 vaccine
World

Pfizer applies for U.S. emergency use for COVID-19 vaccine

The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns.
Published 20 Nov, 2020 05:35pm
Pfizer applies for U.S. emergency use for COVID-19 vaccine
World

Pfizer applies for U.S. emergency use for COVID-19 vaccine

The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns.
Published 20 Nov, 2020 05:35pm